Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...

Multiple myeloma represents an unmet need, emphasizing the significance of continued research and development in this field. Treatment with cemsidomide resulted in notable responses at multiple dose ...

Chicago, May 15, 2025 (GLOBE NEWSWIRE) -- The global multiple myeloma market is witnessing steady growth, fuelled by an aging population, rising disease prevalence, and continuous advancements in ...

Her treatment consisted of rhubarb pills and an infusion of orange peels. Now, 181 years later, multiple myeloma remains incurable, with most patients eventually relapsing or developing treatment ...

Pieter Sonneveld, MD, PhD, chair of the Erasmus MC Cancer Institute, discussed the findings of a study modeling long-term progression-free survival (PFS) in patients with multiple myeloma (MM ...

Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001 in patients with heavily pretreated multiple myeloma to be presented at the 2025 ASCO Annual Meeting NEW YORK ...

What that means is 80% of patients [with myeloma] in the US are being treated in the community. From the moment that a community doctor thinks about CAR T for a patient, and because this is only ...

We have seen effective and efficient mobilization with GPC-100 in combination with G-CSF and propranolol in our multiple myeloma patients, with an excellent safety profile. We look forward to the ...

“There is no cure for multiple myeloma. We believe there remains an unmet medical need for CAR-T therapies that are efficacious, safe, and accessible. Anito-cel has the unique potential to ...

Mulkey is fighting a rare blood cancer known as multiple myeloma that affects one’s white blood cells. There is no cure for the disease. He was hospitalized for more than a month early this year ...